GlassScriptPhysician profile
Adam Greenfest
NPI 1306306188
$629.97
in general payments reported to CMS, 2019-2025
6 companies · $510 in 2025
The $510 reported for 2025 was more than what 79% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $120 · 2025: $510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $388 · Education: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $387.91 |
| Education | $242.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $285.98 | 2025 | Ensite, Cardiomems, Gallant |
| Medtronic, INC. | $144.82 | 2025 | Corevalve Evolut R, Symplicity G3 |
| Amgen INC. | $90.37 | 2024 | Repatha |
| Pfizer INC. | $57.04 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $30.04 | 2024 | |
| Penumbra, INC. | $21.72 | 2025 | Indigo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Greenfest listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.